Kapil Dhingra Replimune Group, Inc. (REPL) insider trading activity

REPL Quotes by TradingView

Kapil Dhingra is Director of Replimune Group, Inc.. Currently has a direct ownership of 0 shares of REPL, which is worth approximately $0. The most recent transaction as insider was on Dec 07, 2020, when has been sold 40,000 shares (Common Stock) at a price of $46.12 per share, resulting in proceeds of $1,844,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Kapil Dhingra Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 07 2020
SELL
Open market or private sale
$1,844,800 $46.12 p/Share
40,000 Reduced 100.0%
0 Common Stock
Dec 07 2020
BUY
Exercise of conversion of derivative security
$70,000 $1.75 p/Share
40,000 Added 50.0%
40,000 Common Stock

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
FPRX
FIVE PRIME THERAPEUTICS, INC.
Director
CRGX
CARGO Therapeutics, Inc.
LVTX
LAVA Therapeutics NV Healthcare
KD

Kapil Dhingra

Director
Woburn, MA

Track Institutional and Insider Activities on REPL

Follow Replimune Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REPL shares.

Notify only if

Insider Trading

Get notified when an Replimune Group, Inc. insider buys or sells REPL shares.

Notify only if

News

Receive news related to Replimune Group, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on REPL